Isracann Prepares to Import Canadian Cannabis into Israel and Europe – World News ReportPosted by On


Regional Demand Drives Strategic Opportunity

/EIN News/ — VANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that the Company has determined to advance foreign importation of Cannabis into Israel in response to perceived opportunity.

The Israeli market for medical cannabis continues to grow at a rapid pace. Now with over 80,000 medical patients (IMCA data), the domestic growers are struggling to keep up with demand. This is good news for Isracann’s farm, which is coming online in the near term.

Additionally, this gap in supply has created a robust cannabis importation market. It has been apparent for some time that Israel has had to rely on Cannabis importation to meet domestic needs. In fact, reports indicate that it is currently the world’s largest importer of Cannabis flower, having surpassed Germany. Recent reports also note Israel has subsequently increased importation quality assurance (QA) requirements. These stringent regulations have eliminated some candidate countries (e.g.: Uruguay) from import licensing. Isracann has observed the situation and noted an uptick in…

Original Author Link click here to read complete story..

Regional Demand Drives Strategic Opportunity

/EIN News/ — VANCOUVER, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that the Company has determined to advance foreign importation of Cannabis into Israel in response to perceived opportunity.

The Israeli market for medical cannabis continues to grow at a rapid pace. Now with over 80,000 medical patients (IMCA data), the domestic growers are struggling to keep up with demand. This is good news for Isracann’s farm, which is coming online in the near term.

Additionally, this gap in supply has created a robust cannabis importation market. It has been apparent for some time that Israel has had to rely on Cannabis importation to meet domestic needs. In fact, reports indicate that it is currently the world’s largest importer of Cannabis flower, having surpassed Germany. Recent reports also note Israel has subsequently increased importation quality assurance (QA) requirements. These stringent regulations have eliminated some candidate countries (e.g.: Uruguay) from import licensing. Isracann has observed the situation and noted an uptick in…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.